Jose Aguilar Gallardo

Cardiology fellow @Tulane. Former IM resident @MountSinaiNYC Morningside/West. 🇭🇳 Views my own

[Jose Aguilar Gallardo @jsaguilarg]

Excited to share our hot off the press review on the Cardio-Renal benefits of SGLT2 inhibitors in HFrEF! @AshishCorrea @Jcontreras75

[European Society of Cardiology Journals @ESC_Journals]

Mechanisms and clinical evidence for the cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in HFrEF https://t.co/siV8HOT1hD

#EHJPharmacotherapy #cardiorenal #heartfailure #cardiotwitter @AgewallStefan @GianluSava

[Tulane Cardiology Fellowship @TulaneCardio]

Tulane Cardiology Reception co-ordinated by Dr. Robert Hendel #ACC24 @TulaneCardio @AIrimpen @WileyJose @swatirao24 @TulaneMedicine at Hudson Grille, Atlanta, GA.

[Jose Aguilar Gallardo @jsaguilarg]

Thank you Dr. Contreras!

[Johanna Contreras, MD, MSc, FACC, FAHA, FHFSA @Jcontreras75]

So proud of my two ⁦mentees and IM residents ⁦@IcahnMountSinai⁩ ! Now Cardiology fellows and soon to become part of our DEIB team ⁦@jsaguilarg⁩ ⁦@MLorenteRos⁩ !! ⁦@MountSinaiHeart⁩ ⁦@ACCinTouch⁩ ⁦@American_Heart⁩

[Jose Aguilar Gallardo @jsaguilarg]

Greatly enjoyed a day of hearing about controversial cases in heart failure from the experts @nyulangone !

[Francisco José Romeo 🇦🇷🇺🇸 @FJRomeoMD]

Please check our last paper entitled "Barriers in Heart Failure Gene Therapy and Approaches to Overcome Them" published at Heart, Lung & Circulation 🇦🇺
Click on the link for a 50-day free access https://t.co/5pbwVYzIp1

[Jose Aguilar Gallardo @jsaguilarg]

@FJRomeoMD @MLorenteRos @kirtipalbhatia @AshishCorrea @Jcontreras75 @slrchiefs @msm_msw @MountSinaiHeart

[Jose Aguilar Gallardo @jsaguilarg]

Excellent study that debunks the “obesity paradox” in patients with heart failure.

It confirms our findings and strengthens our proposal to redefine obesity beyond BMI. Happy to have our study featured on Medpage Today!
https://t.co/4wybrdYsL1
#obesity #Heartfailure #BMI

[EHJ Editor-in-Chief @ehj_ed]

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: no evidence for an ‘obesity-survival paradox’ according to new data.
https://t.co/k720gLwSRV
#HF #Heartfailure #Obesity #BMI #cardiotwitter @ESC_Journals @escardio

[Jose Aguilar Gallardo @jsaguilarg]

Here is the link to our original study https://t.co/dMCZHRYOtQ

[Jose Aguilar Gallardo @jsaguilarg]

@Sarajdiaz1 @MountSinaiHeart Congrats!👏🏼

[Jose Aguilar Gallardo @jsaguilarg]

Thank you @Jcontreras75 ! As always it is an honor to count on your support and to have shared this great experience @MountSinaiHeart @slrchiefs @msm_msw

[Johanna Contreras, MD, MSc, FACC, FAHA, FHFSA @Jcontreras75]

So proud of my incredible resident @jsaguilarg today presenting at the @MountSinaiHeart symposium!! Many sleepless nights paid off. He will be moving to New Orleans for Cardiology fellowship!! Great future ahead @MSMheartSurgery 🎊🎉

[Jose Aguilar Gallardo @jsaguilarg]

@nbharat89 @SLittleMD @smitha_narayana @HMHCardioFellow @HMethodistCV @DipanJShah @NadeenFaza @JuKimMD @WilliamZoghbi Congrats!👏🏼

[Francisco José Romeo 🇦🇷🇺🇸 @FJRomeoMD]

📣Check out our last review by the Ishikawa lab at Mount Sinai entitled “Progress in Clinical Gene Therapy for Cardiac Disorders” just published at Molecular Diagnosis & Therapy.
Link: https://t.co/7Pp4rj93Gp

[Francisco José Romeo 🇦🇷🇺🇸 @FJRomeoMD]

Extremely happy to share our last contemporary review at @JAHA_AHA entitled "Device‐Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies" by the Ishikawa Lab at CVRI @SinaiHeartBlood
https://t.co/SWEQb5RmAb

[Kirtipal Bhatia @kirtipalbhatia]

In this MA of pts with cardiogenic shock requiring VA-ECMO support, concurrent use of Impella (ECPELLA) was associated with a lower risk of short-term mortality. However, pts with ECPELLA had higher rates of hemolysis, limb ischemia, and CRRT.

https://t.co/HQCt5YwXTh.

[Jose Aguilar Gallardo @jsaguilarg]

@FJRomeoMD @MLorenteRos @DrSubratDas @wllclub @Amisha_PatelMD I’m sure it will look fantastic when presented at #TCT2022!

[Jose Aguilar Gallardo @jsaguilarg]

Check out our case report and review of the clinical evidence suggestive of cardiac sarcoidosis in the absence of biopsy/tissue diagnosis
https://t.co/uYyVEuktiw

@javierarreaza @alaahoda2001 Glenmore Lasam @Jcontreras75 @msm_msw @slrchiefs @MountSinaiHeart

[Jose Aguilar Gallardo @jsaguilarg]

Great job my friend! 👏🏼

[Francisco José Romeo 🇦🇷🇺🇸 @FJRomeoMD]

Check out “Cardiac Gene Therapy: Methods & Protocols” textbook (Springer) led by Kiyotake Ishikawa at Mount Sinai, NY. Thrilled to write ✍️ the chapter “Updates on Cardiac Gene Therapy Research and Methods: Overview of Cardiac Gene Therapy”

https://t.co/rAbhNuyNYY

[Jose Aguilar Gallardo @jsaguilarg]

@FionnualaCrowle @slrchiefs Thank you for organizing! It was very helpful

[Jose Aguilar Gallardo @jsaguilarg]

@TomohiroFujisa2 @IcahnMountSinai Thank you Tomo!

[Jose Aguilar Gallardo @jsaguilarg]

Excited to have been selected poster winner at the @IcahnMountSinai GME Consortium Annual Research Day!

[Jose Aguilar Gallardo @jsaguilarg]

@Jcontreras75 Thank you so much! Would not have been possible without your support @Jcontreras75